 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: LEMTRADA (Campath, alemtuzumab) |
|
***************************************************** |
|
#Post#: 2882-------------------------------------------------- |
|
(Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion f |
|
or MS |
|
By: agate Date: April 20, 2020, 12:29 pm |
|
--------------------------------------------------------- |
|
From Multiple Sclerosis Journal (April 20, 2020)--"Acute |
|
cardiotoxicity associated with alemtuzumab infusion for multiple |
|
sclerosis": |
|
https://journals.sagepub.com/doi/abs/10.1177/1352458519855725 |
|
The first part of an editorial commentary on this case, in the |
|
same issue of the MS Journal--"Alemtuzumab: Rare serious adverse |
|
events of a high-efficacy drug": |
|
https://journals.sagepub.com/doi/abs/10.1177/1352458520913277 |
|
***************************************************** |
